ArticleEnvironmental monitoring and assessment2026
Marine pharmaceutical monitoring with POCIS: sampling rate uncertainty, and implications for regulation.
Article in Environmental monitoring and assessment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
POCIS passive samplers were deployed at differently polluted marine sites in the cities of Helsinki and Tallinn and in an open part of the Gulf of Finland. The aim was to determine baseline concentration levels for pharmaceuticals in water monitored with passive sampling techniques, which could also be applied to regulatory monitoring. That baseline concentration data method could then be applied to other sites in the Tallinn and Helsinki area to assess whether the pharmaceutical concentration is elevated or at the baseline level. Altogether, 150 pharmaceuticals were analysed from passive and grab water samples, and 30 substances were discovered. The number of pharmaceuticals detected in passive samplers (27) was higher than in grab samples (20). However, the study revealed the presence of several pharmaceuticals even from expected background sites, such as the open sea site in Gulf of Finland, implying their ubiquitous presence in the study area. The passive sampling results have been converted to TWAC with sampling rate, which is characteristic of the sampler type and studied compound. We assessed the suitability and differences of sampling rates collected from the literature, calculated from LogK
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.